Mark Plevin and Monique Almy Named to 2022 Lawdragon 500 Leading U.S. Bankruptcy and Restructuring Lawyers List
Firm News | 1 min read | 02.08.22
Washington – February 7, 2022: Lawdragon namedCrowell & Moring partners Mark Plevin and Monique Almy to its 2022 list of 500 Leading Bankruptcy and Restructuring Lawyers, which honors lawyers who are skilled in financial restructuring, in and out of the courtroom, and assist debtors, creditors, and others involved with distressed companies.
Plevin litigates and tries cases in the bankruptcy and insurance coverage areas. His unusual blend of experience in these two distinct areas has resulted in him assuming a lead counsel role, on behalf of both U.S. and international insurers, in some of the nation's most important asbestos bankruptcy and other mass tort bankruptcy cases, including Boy Scouts of America, Imerys Talc America, Purdue Pharma, and LTL Management. Plevin also litigates major insurance coverage cases and handles trials and appeals in both bankruptcy and insurance matters.
Almy’s practice focuses primarily on corporate bankruptcy, restructuring, and other insolvency-related matters, with an emphasis on creditors' rights. She has practiced in the area of bankruptcy and creditors' rights for more than 30 years and has extensive experience in the representation of lender syndicates, institutional investors, financial institutions, and other parties in bankruptcy cases, out-of-court workouts, enforcement of remedies, and related litigation. In her practice, Almy regularly represents secured and unsecured creditors, debtors, lessors and committees in bankruptcy cases throughout the country. She also has experience representing court-appointed fiduciaries.
For more information and to see the full list, visit here.
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing